The early activation of cochlear implant audio processors is an option that growing numbers of hearing implant clinics now offer. This article summarizes recent publications on early activation in cochlear implantation and its reported impact on patient care, safety, impedance values, fitting parameters, audiological outcomes, complications, and more.

Prof. Dr. Philippe Lefèbvre and Prof. Dr. Joachim Müller share their experiences leading the feasibility study on MED-EL’s Totally Implantable Cochlear Implant (TICI), breakthrough technology that integrates all cochlear implant components—audio processor, microphone, and battery—into one device under the skin.

MED-EL has focused decades of research on residual hearing preservation. Here are the results, along with some of the secrets to our success.

Today we are looking at an exciting case study from MED-EL’s comprehensive surgical video library. An 11-year-old with unilateral conductive hearing loss receives a VIBRANT SOUNDBRIDGE with a Stapes-SH-Coupler.

Professor Mario Zernotti, our guest author, shares insights gained from nearly four decades of experience helping children with conductive hearing loss due to microtia and congenital aural atresia, which occurs most commonly in Andes Mountains of South America.

A cochlear implant electrode serves not only as a crucial bridge between technology and nature that connects recipients to sound. The electrode array can significantly impact hearing outcomes. For instance, there is now growing consensus among researchers that stimulating more of the cochlea is associated with better speech perception and music appreciation. Here is the latest research you need to know to ensure each of your patients can benefit the most from their cochlear implant.